Since that moment, Moderna has taken steps to pave the path to long-term growth -- from cutting costs to focusing on its vast ...
A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being reevaluated, according to Bloomberg News, Bloomberg reports that the review is ...
Moderna's stock dropped over 10% after the FDA's Dr. Peter Marks resigned, signaling potential increased regulatory scrutiny on vaccines. Moderna's financial health remains strong, with ~$9 billion in ...
Moderna had a hoard of $19.3 billion in cash as the Covid-19 vaccine market peaked in early 2022 . That cash pile has been getting smaller ever since. The biotech lost $3.6 billion in 2024, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results